HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.

AbstractOBJECTIVE:
Human papillomavirus (HPV) infections can lead to cervical intraepithelial neoplasia (CIN) lesions, cervical cancer (CC) and genital warts (GWs). This study intended to assess the annual cost of CC, CIN and GW management in Belgium.
METHOD:
A retrospective study using a Belgian Hospital Disease Database (for yearly hospital cost of CC and GW patients) and a clinical expert survey were performed to assess the medical management of CC, CIN and GW patients. Belgian official sources were used to estimate the annual costs of management of CC, CIN and GW patients both from a healthcare payer perspectives (HCPP) and a societal perspective.
RESULTS:
Based on the 667 patients diagnosed annually in Belgium with CC and an annual cost per patient of euro9,716, the total annual cost of CC is euro6.5 million (HCPP). The 10,495 estimated CIN 1, 2 and 3 patients led to an annual cost of euro1.97 million (HCPP). The 7,989 estimated annual number of diagnosed GW patients led to an estimated annual cost of euro2.53 million (HCPP).
CONCLUSION:
HPV-related diseases represent an important burden on Belgian society, especially when considering that the estimates in this study are probably underestimations, as the management costs of other HPV-related diseases (vulvar, vaginal, penile, oropharyngeal (pre-) cancers, recurrent respiratory papillomatosis etc.) are not included in this analysis.
AuthorsLieven Annemans, Vanessa Rémy, Emilie Lamure, Erik Spaepen, Mark Lamotte, Jean-Paul Muchada, Nathalie Largeron
JournalJournal of medical economics (J Med Econ) Vol. 11 Issue 1 Pg. 135-50 ( 2008) ISSN: 1369-6998 [Print] England
PMID19450115 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Belgium (epidemiology)
  • Condylomata Acuminata (economics, epidemiology, therapy)
  • Costs and Cost Analysis
  • Female
  • Health Expenditures (statistics & numerical data)
  • Humans
  • Middle Aged
  • Models, Econometric
  • Papillomavirus Infections (complications, economics, epidemiology, therapy)
  • Retrospective Studies
  • Uterine Cervical Dysplasia (economics, epidemiology, therapy)
  • Uterine Cervical Neoplasms (economics, epidemiology, therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: